Par Pharmaceutical, Inc.
Chestnut Ridge, NY, United States
This page shows every FDA and USDA recall linked to Par Pharmaceutical, Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
8
Total Recalls
2016
First Recall
2020
Most Recent
1
Class I (Most Serious)
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Sep 2, 2020
· Drug
Class II
Terminated
Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY,...
Apr 8, 2020
· Drug
Class II
Terminated
PrediniSONE Tablets, USP 5 mg, 48-count bottle, Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, N...
Mar 25, 2020
· Drug
Class III
Terminated
Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactur...
Feb 19, 2020
· Drug
Class III
Terminated
Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceut...
May 15, 2019
· Drug
Class I
Terminated
Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufact...
Sep 19, 2018
· Drug
Class III
Terminated
Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY,...
Dec 7, 2016
· Drug
Class II
Terminated
Gildess 24 FE 1.5/30 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fuma...
Nov 9, 2016
· Drug
Class III
Completed